Skip to content
Research Article Open access CC BY 4.0

Evaluation of the Use of Intraoperative Subconjunctival Injection of Triamcinolone Acetonide and Limited Peritomy during Bare Scleral Pterygium Excision

Alaa M. Abdelhafez, Samir Yehia Saleh, Abdelsalam Abdalla Mohamed, Ahmed F. Omar

Ophthalmology Research: An International Journal · pp. 30–39 · Published 25 Feb 2021

10.9734/or/2021/v14i130182

Abstract

Aims: To evaluate the efficacy and safety of subconjunctival injection of triamcinolone acetonide (TA) and limited peritomy during bare scleral pterygium excision in preventing pterygium recurrence. Study Design: A prospective non-randomized interventional case series. Place and Duration of Study: All surgeries were done at the department of ophthalmology of Assiut university hospital (27 eyes) and Alforsan eye center in Assiut (3 eyes), Egypt, between November 2017 to December 2019. Methodology: Thirty eyes of 26 patients who underwent pterygium excision with bare sclera combined with intraoperative subconjunctival TA injection and limited peritomy primary pterygium grade 2 (T2, 3 eyes) and grade 3 (T3, 30 eyes). All patients were followed up for 12 months after surgery. Pterygium recurrence and complications were the key outcome steps. Results: Pterygium recurrence was seen in 3 eyes (10.0%) as following: grade 2 in one eye (3.3%) and grade 3 in two eyes (6.7%). Intraocular pressure elevation was observed in 9 eyes (30%). The IOP rise ranged from (22.4 to 37 mmHg). All eyes were successfully treated medically and reached normal values by the end of postoperative sixth month. Conclusion: This procedure appears to be reasonably safe and successful in reducing pterygium recurrence.

Pterygium recurrence triamcinolone acetonide intraocular pressure.

References (31)

  1. 1 Comparison of Conjunctival Autografts, Amniotic Membrane Grafts, and Primary Closure for Pterygium Excision [DOI]
  2. 2 Effect of Pterygium Morphology on Pterygium Recurrence in a Controlled Trial Comparing Conjunctival Autografting With Bare Sclera Excision [DOI]
  3. 3 Corticosteroid-induced glaucoma: a review of the literature [DOI]
  4. 4 Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia [DOI]
  5. 5 Prevalence and risk factors of pterygium: a systematic review and meta-analysis [DOI]
  6. 6 Kanski's Clinical Ophthalmology: A Systematic Approach
  7. 7 Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes® [DOI]
  8. 8 Corneoscleral Melt After Pterygium Surgery Using a Single Intraoperative Application of Mitomycin-C [DOI]
  9. 9 Intraoperative mitomycin C to prevent recurrence of pterygium after excision [DOI]
  10. 10 Intraoperative Application of Topical Mitomycin C for Pterygium Surgery [DOI]
  11. 11 Prevalence, Treatment, and Outcomes of Coexistent Ocular Surface Squamous Neoplasia and Pterygium [DOI]
  12. 12 Prospective Study of Primary Pterygium Surgery using Pterygium Extended Removal Followed by Extended Conjunctival Transplantation [DOI]
  13. 13 Prevalence of and Risk Factors for Pterygium in Rural Adult Chinese Populations of the Bai Nationality in Dali: The Yunnan Minority Eye Study [DOI]
  14. 14 Limbal Autograft Transplantation for Recurrent and Advanced Pterygia [DOI]
  15. 15 Subconjunctival Triamcinolone Acetonide in the Management of Ocular Inflammatory Disease [DOI]
  16. 16 Pterygium: epidemiology prevention and treatment.
  17. 17 A novel role for CRIM1 in the corneal response to UV and pterygium development [DOI]
  18. 18 Conjunctival Autograft for Pterygium Surgery: How Well Does It Prevent Recurrence? [DOI]
  19. 19 Prevalence and Racial Differences in Pterygium: A Cross-Sectional Study in Han and Uygur Adults in Xinjiang, China [DOI]
  20. 20 Current approaches and future directions in the management of pterygium [DOI]
  21. 21 Correlations between histopathologic changes and clinical features in pterygia [DOI]
  22. 22 5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium [DOI]
  23. 23 Simple limbal epithelial transplantation for recurrent pterygium: A case series [DOI]
  24. 24 Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study [DOI]
  25. 25 The prevalence and risk factors for pterygium in South Korea: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010 [DOI]
  26. 26 Fixation and its role in the causation, laterality and location of pterygium: a study in amblyopes and non-amblyopes [DOI]
  27. 27 Effects of intraoperative steroid injection on the outcome of pterygium surgery [DOI]
  28. 28 Endocan Overexpression in Pterygium [DOI]
  29. 29 OUTCOME OF AUTOLOGOUS LIMBAL CONJUNCTIVAL TRANSPLANTATION IN TERMS OF RECURRENCE RATE, AS THE MAIN OUTCOME MEASURE AND COMPLICATIONS AS THE SECONDARY OUTCOME [DOI]
  30. 30 Role of Triamcinolone Acetate Injection in Recurrent Pterygium [DOI]
  31. 31 Comparasion of intraoperative triamcinolone and Bevacizumab with conjuctival autograft alone in pterygium surgery [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

72

Page views

0

PDF downloads

42

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.